CSS
VNRX icon

Cubist Systematic Strategies’s VolitionRx Ltd VNRX Stock Holding History

Cubist Systematic Strategies’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,509
Closed -$57.6K – 4355
2023
Q1 		$57.6K Buy
+1,509
New +$63.1K ﹤0.01% 3546
2021
Q2 		– Sell
-1,588
Closed -$120K – 3125
2021
Q1 		$120K Buy
+1,588
New +$136K ﹤0.01% 2606

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Cubist Systematic Strategies's VNRX Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of VolitionRx Ltd (VNRX) in Q2 2023, closing a stake of 1,509 shares — an estimated $57.6K sold.

Cubist Systematic Strategies first reported a position in VNRX in Q1 2021 and held it in 2 quarters. The position peaked at $120K in Q1 2021. 34 funds tracked by Wall St. Rank hold VNRX as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining VolitionRx Ltd position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,509 VolitionRx Ltd shares in Q2 2023, an estimated $57.6K.
  • Cubist Systematic Strategies first reported a position in VolitionRx Ltd in Q1 2021 and held it in 2 quarters.
  • Cubist Systematic Strategies's VolitionRx Ltd position peaked at $120K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.